**Executive Summary**
This report details India’s advancements in public health through the Universal Immunisation Programme (UIP), highlighting a rise in full immunisation coverage to 98.4% as of January 2026. Key recent developments include the February 2026 launch of a nationwide HPV vaccination campaign for 14-year-old girls and the introduction of an indigenously manufactured Tetanus-Diphtheria (Td) vaccine. The document outlines the program's infrastructure, digital tracking initiatives, and the schedule for protecting citizens against 12 life-threatening diseases.
**Key Points / Main Content**
* **Program Reach and Milestones**
* The UIP is one of the world's largest health programs, providing free vaccines to 2.9 crore pregnant women and 2.54 crore newborns annually.
* India has successfully eradicated smallpox, polio, and maternal and neonatal tetanus.
* Zero-dose children as a percentage of the population declined from 0.11% in 2023 to 0.06% in 2024.
* National Vaccination Day is observed annually on March 16 to commemorate the start of the Pulse Polio Programme in 1995.
* **Recent Vaccine Launches (2026)**
* **Indigenous Td Vaccine:** Launched on February 21, 2026; approximately 55 lakh doses are to be supplied to the UIP by April 2026.
* **Nationwide HPV Campaign:** Launched on February 28, 2026, targeting 14-year-old girls to prevent cervical cancer, with 1.15 crore girls expected to receive the vaccine for free.
* **Immunisation Infrastructure**
* **Mission Indradhanush:** A targeted mission to reach unvaccinated or partially vaccinated populations, aiming for over 90% coverage.
* **Cold-Chain Network:** Includes nearly 30,000 points and over 1.06 lakh ice-lined refrigerators and deep freezers to maintain vaccine potency.
* **Delivery Sites:** Vaccines are administered through Primary Health Centres (PHCs), Community Health Centres (CHCs), and outreach sessions at Anganwadi centres.
* **Digital Health Initiatives**
* **U-Win:** A digital platform launched in October 2024 for registration, appointment scheduling, and maintaining vaccination records (available in 12 languages).
* **eVIN:** The Electronic Vaccine Intelligence Network tracks vaccine stock levels and storage temperatures in real-time.
* **CoWIN:** Facilitated over 220 crore COVID-19 vaccine doses and continues to manage vaccination records.
**Impact Analysis**
**Pregnant Women**
**Impact**
They receive free protection against various diseases, specifically through Td (Tetanus-Diphtheria) shots, reducing maternal mortality and providing early antibodies to newborns.
**Action Required**
Adhere to the prescribed schedule: Td-1 during the first antenatal visit, Td-2 four weeks later, or a Td-Booster if two doses were received within the last three years.
**Infants and Children**
**Impact**
Protection against 12 life-threatening diseases, including tuberculosis, polio, and hepatitis B, through a structured schedule from birth to age 16.
**Action Required**
Guardians must ensure children receive vaccinations at birth, by their 1st and 2nd birthdays, and subsequent boosters at ages 5, 10, and 16.
**14-Year-Old Girls**
**Impact**
Direct access to a nationwide campaign to prevent cervical cancer via the Human Papillomavirus (HPV) vaccine.
**Action Required**
Visit government health facilities to receive the HPV vaccine free of cost as part of the 2026 campaign.
**Frontline Health Workers (ASHAs and Anganwadi Workers)**
**Impact**
They serve as the central link for mobilizing beneficiaries and ensuring service delivery at the village and urban slum levels.
**Action Required**
Mobilize beneficiaries to session sites and utilize digital tools like U-Win to ensure no child or pregnant woman is missed.
**Healthcare Administrators and State Governments**
**Impact**
Responsibility for maintaining the "cold chain" and digital infrastructure to ensure vaccine potency and stock availability.
**Action Required**
Implement "Model Immunisation Centres" and monitor vaccine stock and temperature integrity via the eVIN platform.
Key Entities Referenced
Universal Immunisation Programme (UIP): A national health framework providing free vaccines to newborns, children, and pregnant women against 12 life-threatening diseases.
Ministry of Health and Family Welfare: The primary government body responsible for implementing and managing India's national immunisation initiatives and healthcare infrastructure.
Mission Indradhanush: A targeted outreach program launched to achieve over 90% immunisation coverage by reaching unvaccinated or partially vaccinated populations in hard-to-reach areas.
U-Win: A digital platform and application designed to facilitate vaccination registration, track doses, and maintain electronic records for routine immunisation.
Electronic Vaccine Intelligence Network (eVIN): A technology system used to monitor vaccine stock levels and storage temperatures in real-time across the national cold chain network.
PIB Headquarters
Celebrating the Power of Vaccines
Posted On: 17 MAR 2026 12:38PM by PIB Delhi
Key Takeaways
India has eradicated smallpox, polio and maternal & neonatal tetanus through vaccination, and continues
to expand its immunisation programme — most recently launched HPV and indigenous Td vaccines in
2026.
The UIP is one of the world's largest immunisation programmes, reaching 2.9 crore pregnant women and
2.54 crore newborns every year, free of cost.
Full immunisation coverage has risen from 62% in 2015 to 98.4% in January 2026.
Percentage of zero-dose children to the total population has declined from 0.11% in 2023 to 0.06% in
2024.
National Vaccination Day
Immunisation through vaccination saves crores of lives every year by reducing the risks of contracting
diseases. It builds people's natural defences to create protection against illnesses.
In India, vaccines have had resounding impact on the improvement of public health. Apart from polio,
vaccines have eradicated smallpox, and eliminated yaws, polio and maternal & neonatal tetanus in India.
They have reduced child mortality rates, measles-rubella, and tuberculosis. During COVID-19, India, the
pharmacy of the world, supplied over 200 crore COVID-19 vaccine doses, including indigenously
developed and licensed vaccines manufactured in India. In 2026, the Government of India launched
nation-wide HPV vaccination campaign for girls aged 14 years to protect from cervical cancer, and an
indigenously manufactured tetanus-diphtheria (Td) vaccine.India’s robust Universal Immunisation Programme (UIP), a wide-spread network of publicly funded
healthcare centres, workers and cold-chain infrastructure, and a strong digital network, have delivered
results.
Full immunisation coverage has risen from 62% in 2015 to 98.4% as of January 2026. India’s percentage
of zero-dose children to the total population has declined from 0.11% in 2023 to 0.06% in 2024. India has
a long history of prioritising vaccination, and it continues to push for higher vaccination rates to further
improve public health through the Universal Immunisation Programme.
India celebrates National Vaccination Day on March 16 every year to commemorate the first dose of the
Oral Polio Vaccine given to citizens in 1995, under the Pulse Polio Programme launched in the same year.
The programme, launched in 1995, successfully eliminated polio in India, with the last case in India
reported on January 13, 2011, in Howrah, West Bengal.Universal Immunisation Programme
Mothers pass antibodies to their babies when they are born. However, these antibodies, which are
transferred from the mother to the child through pregnancy and breast milk, only provide immune
protection for the first few months of a newborn’s life.
Vaccines are crucial to protect babies and infants from germs and even life-threatening diseases. It is best
to give vaccines to children before they are exposed to the illnesses – ideally within the first 12 to 18
months of their lives.
The Universal Immunisation Programme, launched in 1985 and implemented by the Ministry of Health
and Family Welfare, aims to provide free vaccines to children and pregnant women against various
diseases. The programme reaches about 2.9 crore pregnant women and 2.54 crore newborns every year.The objectives of the UIP are:
(cid:0) To increase immunisation coverage
(cid:0) To improve the quality of services
(cid:0) To establish a reliable cold chain system to the health facility level
(cid:0) Monitoring of performance
(cid:0) To achieve self-sufficiency in vaccine production
The UIP provides vaccines to newborns, children, adolescents and pregnant women for protecting against
12 diseases. The Japanese Encephalitis vaccine is provided to people only in endemic districts, and the rest
are provided nationally.
In the past decade, various new vaccines were added to the programme – Inactivated Polio Vaccine (IPV)
(2015), Rotavirus Vaccine (RVV) (2016), Measles-Rubella (MR) vaccine (2017) and Pneumococcal
Conjugate Vaccine (PCV) (2017). The vaccines given under UIP are:
Bacillus Calmette-Guérin (BCG)
Diphtheria, Pertussis and Tetanus (DPT)
Tetanus and adult Diphtheria (Td)
Bi valent oral polio vaccine (bOPV)
Measles-Rubella (MR) vaccine
Hepatitis B (Hep B)
Pentavalent — DPT + Hepatitis B + Haemophilus Influenzae type b (DPT + Hep B + Hib)
Rotavirus Vaccine (RVV)
Pneumococcal Conjugate Vaccine (PCV)
Japanese Encephalitis (JE) Vaccine
These vaccines protect against life-threatening diseases.
# Disease Disease Description
1 Tuberculosis (severe childhood form) Bacterial infection affecting the lungs; can spread
to the brain and multiple organs
2 Diphtheria Bacterial infection affecting the throat; can damage
the heart and nerves
3 Pertussis (Whooping Cough) Highly contagious cough illness, dangerous for
infants
4 Tetanus Bacterial infection from contaminated wounds
causing muscle stiffness
5 Polio Viral infection attacking the nervous system; can
cause permanent paralysis or death
6 Measles Highly contagious viral disease, causes fever and
rash7 Rubella Mild viral illness with fever & rash; spreads
through coughing and sneezing
8 Hepatitis B Viral infection of the liver that can become chronic
and cause liver damage
9 Meningitis & Pneumonia (Hib) Meningitis — infection and inflammation of the
membranes surrounding the brain and spinal cord
Pneumonia — infection and inflammation of the
lungs
10 Rotavirus Diarrhoea Viral infection causing severe diarrhoea in infants
11 Pneumococcal Pneumonia Bacterial lung infection causing fever and breathing
difficulty
12 Japanese Encephalitis Mosquito-borne viral disease-causing brain
inflammation
National Immunisation Schedule
Getting vaccines in a timely manner is important for protection from life-threatening diseases. This is the
prescribed schedule under the UIP for pregnant women, and infants and children.
Pregnant Women
Td-1: As early as possible during the First Antenatal visit
Td-2: 4-weeks after first Td shot
Td-Booster: If two Td doses already received in a previous pregnancy within the last 3 years
All doses ideally given before 36 weeks — but administered even if missed, including during labour
Infants and Children
At birth –
Hep B
bOPV
BCGBy 1st birthday –
3 doses of bOPV,
3 doses of rotavirus vaccine
3 doses of pentavalent
3 doses of fractional IPV
3 doses of PCV
1st dose of MR vaccine
1st dose of JE vaccine (where applicable)
By 2nd birthday –
2nd dose of MR vaccine
1st dose of DPT booster
1 dose of bOPV booster
2nd dose of VE vaccine (where applicable)
After 5th birthday –
2nd dose of DPT booster at 5 years of age
1 dose of Td vaccine at 10 years
1 dose of Td vaccine at 16 years
Recent Vaccine Launches & Programmes
The most recent chapter in this expansion is also the most ambitious — with two landmark launches in
early 2026 that extend UIP's reach.
Indigenous Tetanus–Diphtheria (Td) Vaccine Launch (2026)
An indigenously manufactured Tetanus & Adult Diphtheria (Td) vaccine was launched on 21 February
2026. The vaccine is produced at the Central Research Institute (CRI), Kasauli. About 55 lakh doses
will be supplied to the Universal Immunisation Programme (UIP) by April 2026.India's domestic vaccine manufacturing capacity underpins this entire edifice. As the world's largest
vaccine producer, India supplies approximately 60% of global vaccines. The launch of the indigenously
manufactured Td vaccine is an expression of self-reliance.
Nationwide HPV Vaccination Campaign (2026)
A nationwide Human Papillomavirus (HPV) vaccination campaign was launched on 28 February 2026.
The campaign was launched from Ajmer, Rajasthan by Prime Minister Narendra Modi. It targets 14-
year-old girls to protect them from cervical cancer. Around 1.15 crore girls across India are expected to
receive the vaccine free of cost at government health facilities.
Mission Indradhanush
To reach children and pregnant women who are unvaccinated or partially vaccinated, the government
launched the Mission Indradhanush programme in 2015, following it with Intensified Mission
Indradhanush Missions (with a greater focus on urban areas), with greater interministerial convergence.
These missions aim to achieve over 90% full immunisation coverage under the UIP by strengthening
routine immunisation services and targeting hard-to-reach populations.
12 phases of Mission Indradhanush have been held so far until 2023, vaccinating 5.46 crore infants and
1.32 crore pregnant women across 765 districts.
Infrastructure Supporting UIP Implementation
Community Health Centres and Workers
Where are the Vaccines Provided?
UIP vaccines are provided free of cost to all beneficiaries at fixed sites such as Primary Health Centres
(PHCs), Community Health Centres (CHCs) and Government hospitals, at sub-centres, and through
outreach sessions held at Anganwadi centres or at other identified locations within villages. Since 2005,
UIP is under the National Rural Health Mission. Under this mission, UIP is also implemented in urban
slums.
Frontline health workers – ASHAs (Accredited Social Health Activists), Anganwadi Workers (AWWs)
and link workers — play a central role in mobilising beneficiaries to session sites and ensuring no child or
pregnant woman is missed.
Model Immunisation Centres
The Government of India encourages states and union territories to have model immunisation centres.
They are already operational in Uttar Pradesh, Bihar and the union territories of Chandigarh and Ladakh.
Cold-Chain Network
Vaccines must be stored continuously within a limited temperature range — from the time they are
manufactured to the moment of vaccination. Temperatures that are too high or too low can cause a vaccine
to lose its potency (its ability to protect against disease), and once lost, potency cannot be regained orrestored. The system for storing and transporting vaccines within these prescribed conditions is called a
cold chain system. It forms part of the broader vaccine supply chain, which must remain uninterrupted
and efficient to ensure immunisation coverage and outreach.
India's vaccine cold chain is one of the largest in the world — spanning nearly 30,000 cold chain points,
from Government Medical Supply Depots at the national level down to Primary Health Centres at the sub-
district level. These storage points at hospitals, community health centres, primary health centres and other
health facilities are equipped with over 1.06 lakh ice-lined refrigerators and deep freezers, and 432
walk-in cooler and walk-in freezers for bulk vaccine storage. Conducting over 1.3 crore immunisation
sessions annually across this network, maintaining temperature integrity at every point is critical to
ensuring vaccines reach the last beneficiary in potent condition.
To digitise and strengthen this vast infrastructure, the Ministry of Health and Family Welfare uses the
Electronic Vaccine Intelligence Network (eVIN) — a state-of-the-art software platform that tracks
vaccine stock levels and storage temperatures in real time at multiple locations across the country, backed
by strong IT infrastructure and trained professionals. eVIN has expanded nationwide across all
States/UTs. The platform proved critical during the COVID-19 pandemic, enabling the vaccination of a
record number of people in a short period of time.
Digital Initiatives
India’s immunisation management system has been upgraded through a robust digital ecosystem with
platforms for registration, appointment scheduling, vaccine tracking and real-time monitoring.
U-Win
U-Win is a digital platform and app to help people find vaccination centres near their residence, manage
vaccination appointments at health facilities and maintain vaccination records.
One user can register up to 10 people in one mobile number, including citizens/guardians, pregnant
women, infants (0-1 years), children (1-7 years) and adolescents (7-19 years). U-Win was launched in
October 2024 and is available in 12 languages including English.
CoWIN
Like U-Win, CoWIN is a digital platform for COVID-19 vaccination registration at health and other
centres, and for managing vaccination appointments and records. It was launched on January 16, 2021,
and since then, over 220 crore doses have been administered through it, of which only 56.28 lakh are not
through CoWIN.
Impact
Vaccination is one of several factors — alongside improvements in nutrition, sanitation, maternal care, and
healthcare access — behind India's broader gains in child and pregnant women survival rates. Better-
nourished, better-immunised women face lower risks during pregnancy and childbirth, while stronger
healthcare systems that deliver vaccines also expand access to skilled birth attendants and emergency
obstetric care, reducing maternal mortality.The newer vaccines — rotavirus, PCV, and Measles-Rubella — have directly targeted the leading
infectious causes of child death. The percentage of zero-dose children against the country population, has
been halved, from 0.11% in 2023 to 0.06% in 2024 — an achievement acknowledged by the UN Inter-
Agency Group for Child Mortality Estimation (2024) in positioning India as a global exemplar in
child health.
Vaccination campaigns do more than protect public health — they reduce the financial burden of illness
on families, keeping children healthy and allowing them to live fuller, more meaningful lives. The benefits
extend across generations: a healthy child becomes a healthy adult, and a healthy population contributes
more productively to the workforce, driving broader social and economic progress.
Conclusion
From eradicating Smallpox in 1977 to eliminating Polio and Neonatal Tetanus, administering 200 crore
COVID-19 doses, and now pursuing Measles-Rubella elimination — India's immunisation journey is one
of verified, milestone-by-milestone achievement.
References
https://www.pib.gov.in/PressReleseDetailm.aspx?PRID=2151236®=3&lang=2#:~:text=Special%20va
ccination%20campaigns%20such%20as,are%20carried%20out%20every%20year.
https://www.who.int/news-room/questions-and-answers/item/vaccines-and-immunization-vaccine-safety
https://www.pib.gov.in/PressReleasePage.aspx?PRID=2140343®=3&lang=2https://www.who.int/news-room/feature-stories/detail/how-do-vaccines-work
https://www.who.int/news-room/feature-stories/detail/vaccine-efficacy-effectiveness-and-protection
https://www.pib.gov.in/PressReleasePage.aspx?PRID=2124032®=3&lang=2#:~:text=In%202024%2
C%20India%20has%20recorded,cases%20in%20comparison%20with%202023
https://nhmodisha.gov.in/wp-content/uploads/2024/02/UIP.pdf#:~:text=Full%20Immunization:%20To%20
fully%20immunize%20each%20child,of%20JE%20before%201%20year%20of%20age.
https://www.mohfw.gov.in/sites/default/files/Universal.pdf
https://ncvbdc.mohfw.gov.in/index1.php?lang=1&level=2&sublinkid=5922&lid=3759
https://mohfw.gov.in/sites/default/files/Unit1IntroductiontoimmunizationandroleofmedicalofficersinImmu
nization.pdf
Diphtheria: https://www.who.int/news-room/fact-sheets/detail/diphtheria
Pertussis: https://www.who.int/health-topics/pertussis#tab=tab_1
Tetanus: https://www.who.int/news-room/fact-sheets/detail/tetanus
Polio: https://www.who.int/news-room/fact-sheets/detail/poliomyelitis
Measles: https://www.who.int/news-room/fact-sheets/detail/measles
Rubella: https://www.who.int/news-room/fact-sheets/detail/rubella
Tuberculosis: https://www.who.int/news-room/fact-sheets/detail/tuberculosis
Hepatitis: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b#:~:text=Hepatitis%20B%20is%20
a%20viral,boosters%20a%20few%20weeks%20later.
HIB: https://www.nhs.uk/conditions/hib/
Rotavirus: https://www.who.int/westernpacific/health-topics/rotavirus-infections#tab=tab_1
Pneumococcal: https://www.cdc.gov/pneumococcal/about/index.html
Encephalitis: https://www.who.int/news-room/fact-sheets/detail/japanese-encephalitis
https://www.pib.gov.in/PressReleasePage.aspx?PRID=1966931®=3&lang=2
https://mohfw.gov.in/sites/default/files/Unit1IntroductiontoimmunizationandroleofmedicalofficersinImmu
nization.pdf
https://www.pib.gov.in/PressReleaseIframePage.aspx?PRID=2140343
https://www.unicef.org/india/stories/ModelImmunisationCentre
https://www.who.int/publications/m/item/vaccine-vial-monitor#:~:text=Overview,Portugu%C3%AAs
https://www.pib.gov.in/PressReleasePage.aspx?PRID=1643172
https://www.undp.org/india/blog/evin-co-win-digitizing-indias-immunisation-programme#:~:text=eVIN%
20is%20a%20smart%20vaccine,and%20pregnant%20mothers%20on%20time.
https://pmc.ncbi.nlm.nih.gov/articles/PMC8928793/
https://www.pib.gov.in/PressReleasePage.aspx?PRID=2021153
https://www.unicef.org/supply/what-cold-chain
https://dashboard.cowin.gov.in/
https://www.pib.gov.in/PressReleasePage.aspx?PRID=2140343
chrome-
extension://efaidnbmnnnibpcajpcglclefindmkaj/https://nccmis.mohfw.gov.in/document/RI_Manual_For_Health_Worker
See in PDF
PIB Research Unit
(Release ID: 2241066) Visitor Counter : 349
Read this release in: ही , Gujarati